Turner syndrome presents medical and developmental challenges due to monosomy X
Extensive clinical literature establishes that Turner syndrome, caused by monosomy X, presents a wide spectrum of medical and developmental challenges, notably including cardiovascular, endocrine, metabolic, and neurocognitive complications.
All retrieved papers uniformly support the claim that Turner syndrome (driven by monosomy X or X chromosome abnormalities) presents numerous medical and developmental challenges, including cardiovascular, metabolic, hepatic, and endocrine issues. There is zero dissenting evidence.
Virginia P. Sybert. Cardiovascular Malformations and Complications in Turner Syndrome. 1998. https://doi.org/10.1542/peds.101.1.e11
Paper 0 establishes that Turner syndrome is associated with significant cardiovascular malformations and complications.
See more details
Siddharth K. Prakash, D. Guo, C. Maslen, M. Silberbach, G. Investigators, D. Milewicz, C. Bondy. Single Nucleotide Polymorphism Array Genotyping is Equivalent to Metaphase Cytogenetics for Diagnosis of Turner Syndrome. 2013. https://doi.org/10.1038/gim.2013.77
Paper 1 notes that Turner syndrome is a developmental disorder caused by partial or complete monosomy for the X chromosome.
Lindsey Guzewicz, S. Howell, C. Crerand, Hailey Umbaugh, Natalie J. Nokoff, Jennifer Barker, S. Davis. Clinical Phenotype and Management of Individuals with Mosaic Monosomy X with Y Chromosome Material Stratified by Genital Phenotype. 2021. https://doi.org/10.1002/ajmg.a.62127
Paper 2 demonstrates that individuals with monosomy X face notable medical and neurodevelopmental risks.
Najma Khan, Anam Farooqui, R. Ishrat. Turner Syndrome where are we?. 2024. https://doi.org/10.1186/s13023-024-03337-0
Paper 3 outlines how Turner syndrome results from the loss of an X chromosome, leading to numerous complications like short stature, cardiovascular and endocrine issues, and neurocognitive deficits.
Lily Jones, J. Blair, Daniel B Hawcutt, G. Lip, Alena Shantsila. Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions. 2022. https://doi.org/10.1097/HJH.0000000000003321
Paper 4 highlights that Turner syndrome carries a high risk of early-onset hypertension and acquired cardiovascular disease.
L. Galian-Gay, J. Rodríguez-Palomares. Turner syndrome and aortic complications: more benign than previously thought. 2022. https://doi.org/10.1136/heartjnl-2022-321330
Paper 5 details how Turner syndrome, characterized by monosomy X, presents severe cardiovascular challenges such as aortic dilation and dissection.
Mariola Krzyścin, Elżbieta Sowińska-Przepiera, Karolina Gruca-Stryjak, Ewelina Soszka-Przepiera, Igor Syrenicz, Adam Przepiera, Ž. Bumbulienė, A. Syrenicz. Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?. 2024. https://doi.org/10.3390/biomedicines12051034
Paper 6 documents the unique metabolic and cardiovascular risk profile associated with Turner syndrome, including visceral adiposity and hypertension.
I. Bedei, J. Bruder, I. B. Lund, S. H. Thomsen, Ida Vogel, A. Maciel-Guerra, Francisco Álvarez-Nava, Melissa L Crenshaw, R. Axt-Fliedner, C. H. Gravholt, A. Skakkebæk. Non‐Invasive Prenatal Testing by Cell‐Free DNA (cfNIPT) for Detecting Turner Syndrome With Mosaicism and Structural Variants—Prenatal Findings and Postnatal Outcomes. 2025. https://doi.org/10.1002/ajmg.c.32136
Paper 7 notes that Turner syndrome is a sex chromosomal disorder associated with various phenotypic challenges and congenital malformations.
Sophie Howarth, R. Quinton. Missed opportunities in the treatment of Turner syndrome: a case discussion and review of the guidelines. 2022. https://doi.org/10.1136/bcr-2022-250870
Paper 8 discusses the clinical features and associated complications of Turner syndrome that require ongoing screening and management.
Mohamad Jamalinia, A. Lonardo, Ralf Weiskirchen. Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective. 2026. https://doi.org/10.1002/cdt3.70038
Paper 9 explains that Turner syndrome (monosomy X) carries a clinically significant burden of liver disease and cardio-renal-metabolic challenges.
Ke Wan, Emma Brown, R. Krishnaswamy, P. Kaub. Turner Syndrome.. 2025. https://doi.org/10.1111/jpc.70132
Paper 10 summarizes the postnatal phenotype of Turner syndrome, including short stature, delayed puberty, and cardiac, endocrine, and autoimmune disorders.
W. Abdullah, Abdulameer Jawad al-Gburi, Saba Younis Al-Obaidi. Cardiovascular health in turner syndrome: Manifestations, endocrine, and metabolic risk factors with a look at clinical practice. 2022. https://doi.org/10.4103/mj.mj_13_22
Paper 11 confirms that Turner syndrome features high overall mortality and various congenital and acquired cardiovascular manifestations.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt